Jump to navigation Jump to search
- "Souvien Therapeutics, Ltd.". Juvenescence. Retrieved 28 April 2021. "Souvien Therapeutics, Ltd. is a biotechnology company focused on developing novel therapeutic agents to modulate critical epigenetic mechanisms associated with neurodegeneration. [...] The development plan is based on a substantial body of data implicating a critical epigenetic regulator of cellular aging in neurodegeneration. The goal is to use that knowledge, and the greatly evolving understanding of aging, to bring new drugs into human trials."